Flaggemelding, Salix AS - Gentian Diagnostics ASA

26. Aug 2021 | 1 min read

Salix AS har 25. august 2021 solgt 10481 aksjer i Gentian Diagnostics ASA til
gjennomsnittlig pris 66,12kr. Salix AS går med dette under 5% eierskap og eier
nå 4,98% av Gentian Diagnostics ASA. Salix AS eier etter transaksjonen 767422
aksjer og stemmeretter.

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Read more

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Read more

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Read more